Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.
Saved in:
| Title: | Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study. |
|---|---|
| Authors: | Benavente Y; Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Department of Public Health, Mental Health and Maternal and Child Health Nursing, Faculty of Nursing, Universitat de Barcelona, Barcelona, Spain., Hermosa S; Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Papadimitriou N; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France., Clay-Gilmour A; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA., Brown EE; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lan Q; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Purdue M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bhatti P; Division of Population Oncology, BC Cancer, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.; Population Health Sciences, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Cozen W; Division of Hematology-Oncology, Department of Medicine, University of California Irvine, Orange, California, USA., Norman A; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Slager SL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Rajkumar V; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Kumar SK; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Vachon CM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Novak AJ; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Habermann TM; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Link BK; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer and Weill Cornell Medical College, New York, New York, USA., Ghesquieres H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre Benite, France., Bracci PM; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA., Holly E; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA., Griffin RG; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hildebrandt MAT; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vermeulen RCH; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands., Kolijn PM; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands., Hjalgrim H; Haematology, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.; Department of Haematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark., Smedby KE; Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Jayasekara H; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia.; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., Cheah S; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia., Monnereau A; Epidemiology of Childhood and Adolescent Cancers Group, Inserm, Center of Research in Epidemiology and Statistics Sorbonne, Paris, France.; Paris Cité (CRESS), Université Paris Descartes, Paris, France.; Registre des Hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux, France., Chen Y; NYU Grossman School of Medicine, New York, New York, USA., Arslan A; NYU Grossman School of Medicine, New York, New York, USA., Zhang Y; Department of Cancer Prevention and Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Camp NJ; Huntsman Cancer Institute and Division of Hematology and Hematological Malignancies, University of Utah School of Medicine, Salt Lake City, Utah, USA., Sborov DW; Huntsman Cancer Institute and Division of Hematology and Hematological Malignancies, University of Utah School of Medicine, Salt Lake City, Utah, USA., Osman AEG; Huntsman Cancer Institute and Division of Hematology and Hematological Malignancies, University of Utah School of Medicine, Salt Lake City, Utah, USA., Ziv E; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., De Vivo I; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Joseph V; Niehaus Center for Inherited Cancer Genomics and Department of Medicine, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Teras LR; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA., Patel AV; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA., Kane E; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK., Vajdic CM; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia., Guilloteau A; Registre des Hémopathies Malignes de Côte d'Or, Dijon, France.; INSERM U1231 CTM, Epi2THM Team, Université de Bourgogne, Dijon, France., Cocco P; Centre for Occupational and Environmental Health, Division of Public Health, Health Services Research Primary Care, University of Manchester, Manchester, UK.; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Alemany L; Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Sainz J; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada (UGR), Granada, Spain.; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain., McKay J; IARC, Lyon, France., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Casabonne D; Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. |
| Source: | British journal of haematology [Br J Haematol] 2026 Jun; Vol. 208 (6), pp. 1942-1953. Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
